A Small Biopharma's View Of Working With CROs

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL

Running a clinical-stage oncology biopharma with only five employees means you quickly learn a thing or two about the value of outsourcing services.

For Pamela Contag, Ph.D., cofounder and CEO of BioEclipse Therapeutics, those learnings have led to her company using five CROs to get CRX-100, BioEclipse’s lead investigational candidate, through approval.